03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Terry Flotte
MD, Editor in Chief of Human Gene Therapy, President of the American Society of Gene and Cell Therapy
press citation on 1 topic since 13 May 2026 · last quoted 13 May 2026
02 Quoted on · 1 of 29 topics
Terry Flotte: key facts
- Kind of voice
- Academic
- Role
- MD, Editor in Chief of Human Gene Therapy, President of the American Society of Gene and Cell Therapy
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 13 May 2026
04 The signal · where Terry Flotte sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Lindsey GeorgeAcademicMD, Children's Hospital of Philadelphia1
- 25=Rebecca Ahrens-NiklasAcademic1
- 25=Terry FlotteAcademicMD, Editor in Chief of Human Gene Therapy, President of the American Society of Gene and Cell Therapy1
- 25=Dr. Ludi Dhyani RahmartaniClinicianPediatric Specialist at Universitas Indonesia and RSUPN Dr. Cipto Mangunkusumo Hospital1
- 25=Dr. Muhammad Jawad HassanAcademicMedical Geneticist at Shifa International Hospital and Professor of Biosciences at Shifa Tameer-e-Millat University1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Terry Flotte has said
- genengnews.com1
Where Terry Flotte has been quoted
- 01ASGCT President Terry Flotte Touts Rare Disease Initiatives as His Term Endsgenengnews.com · 13 May 2026
Verbatim
“We're working very hard on access for rare and ultra-rare conditions and have been for some time. You'll see that in the presidential symposium. This is in the context of our mission to improve access to rare disease cell and gene therapy (CGT).”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.